Literature DB >> 29075661

Corrigendum to "Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease".

Aikaterini Thanou1, Tauseef Ali2,3,4, Omar Haq2,3, Sindhu Kaitha2,3, Jordan Morton3, Stavros Stavrakis3, Mary Beth Humphrey3,4.   

Abstract

[This corrects the article DOI: 10.1155/2013/862312.].

Entities:  

Year:  2017        PMID： 29075661      PMCID： PMC5624138          DOI： 10.1155/2017/2365840

Source DB:  PubMed          Journal:  Int Sch Res Notices        ISSN： 2356-7872


In the article titled “Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease” [1], there was an error regarding the FRAX® tool, which should be clarified as follows. The article notes, “the WHO fracture risk predictor model (FRAX) designed to incorporate such factors in a comprehensive assessment tool has shown promising preliminary results in patients with IBD”. However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
  2 in total

1.  Clarifying WHO's position on the FRAX® tool for fracture prediction.

Authors:  Nathan Ford; Susan L Norris; Suzanne R Hill
Journal:  Bull World Health Organ       Date:  2016-12-01       Impact factor: 9.408

2.  Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease.

Authors:  Aikaterini Thanou; Tauseef Ali; Omar Haq; Sindhu Kaitha; Jordan Morton; Stavros Stavrakis; Mary Beth Humphrey
Journal:  ISRN Gastroenterol       Date:  2013-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.